FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017658047> ?p ?o ?g. }

• W2017658047 endingPage "88" @default.
• W2017658047 startingPage "78" @default.
• W2017658047 abstract "The immunogenicity, allergenicity, and cross-reactivity of aztreonam were investigated in 21 patients with cystic fibrosis (CF) (aged 5 to 39 years) with well-documented histories of allergic systemic reactions (SRs) to penicillin and/or cephalosporin antipseudomonal beta-lactam antibiotics (BLAs). Skin tests (STs) with penicilloyl-polylysine (PPL), penicillin minor determinant mixture, and antipseudomonal BLA were positive in 19 patients (90%). The BLA causing the most recent allergic reaction, minor determinant mixture, or PPL, was positive in 89%, 53%, and 32% of ST-positive patients, respectively. Serum PPL-specific IgE antibodies were not detectable, although PPL-specific IgG antibodies were found in 64% of patients tested. STs to aztreonam reagents were performed and were initially negative in 20 patients. One patient was ST positive to the polylysine conjugate of hydrolyzed aztreonam (SQ 27629), despite no prior exposure to aztreonam, and was not treated. Of 20 patients treated with aztreonam, four were demonstrated to be sensitized by exposure (one had an SR during initial treatment course, two had SRs on reexposure, and one patient was asymptomatic after intravenous desensitization) by positive aztreonam reagent skin responses on repeat testing. Aztreonyl-specific IgE and IgG serum antibodies were not detected in any patients, including patients with allergic reactions to aztreonam. Thus, aztreonam is generally well tolerated in high-risk patients with CF allergic to other BLAs and appears to have reduced immunogenicity by serologic testing. However, caution should be exercised with aztreonam in BLA-allergic patients with CF in light of 5% preexisting ST cross-reactivity and 20% sensitization rates found in this study." @default.
• W2017658047 created "2016-06-24" @default.
• W2017658047 creator A5022053553 @default.
• W2017658047 date "1991-01-01" @default.
• W2017658047 modified "2023-10-09" @default.
• W2017658047 title "Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis" @default.
• W2017658047 cites W1532190041 @default.
• W2017658047 cites W1972941889 @default.
• W2017658047 cites W1985426071 @default.
• W2017658047 cites W1987952120 @default.
• W2017658047 cites W1988020078 @default.
• W2017658047 cites W2004122253 @default.
• W2017658047 cites W2006717800 @default.
• W2017658047 cites W2010952365 @default.
• W2017658047 cites W2019825226 @default.
• W2017658047 cites W2026582524 @default.
• W2017658047 cites W2027848425 @default.
• W2017658047 cites W2029591367 @default.
• W2017658047 cites W2029900463 @default.
• W2017658047 cites W2040104588 @default.
• W2017658047 cites W2062135158 @default.
• W2017658047 cites W2065164921 @default.
• W2017658047 cites W2070075469 @default.
• W2017658047 cites W2070828600 @default.
• W2017658047 cites W2073751032 @default.
• W2017658047 cites W2076753996 @default.
• W2017658047 cites W2112729164 @default.
• W2017658047 cites W2318497019 @default.
• W2017658047 cites W2318597002 @default.
• W2017658047 cites W2322234263 @default.
• W2017658047 cites W2330931586 @default.
• W2017658047 cites W2334004249 @default.
• W2017658047 cites W2485861084 @default.
• W2017658047 doi "https://doi.org/10.1016/0091-6749(91)90215-a" @default.
• W2017658047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1991925" @default.
• W2017658047 hasPublicationYear "1991" @default.
• W2017658047 type Work @default.
• W2017658047 sameAs 2017658047 @default.
• W2017658047 citedByCount "53" @default.
• W2017658047 countsByYear W20176580472013 @default.
• W2017658047 countsByYear W20176580472014 @default.
• W2017658047 countsByYear W20176580472015 @default.
• W2017658047 countsByYear W20176580472016 @default.
• W2017658047 countsByYear W20176580472017 @default.
• W2017658047 countsByYear W20176580472018 @default.
• W2017658047 countsByYear W20176580472019 @default.
• W2017658047 countsByYear W20176580472021 @default.
• W2017658047 countsByYear W20176580472022 @default.
• W2017658047 countsByYear W20176580472023 @default.
• W2017658047 crossrefType "journal-article" @default.
• W2017658047 hasAuthorship W2017658047A5022053553 @default.
• W2017658047 hasBestOaLocation W20176580471 @default.
• W2017658047 hasConcept C126322002 @default.
• W2017658047 hasConcept C159654299 @default.
• W2017658047 hasConcept C203014093 @default.
• W2017658047 hasConcept C2776217527 @default.
• W2017658047 hasConcept C2776938444 @default.
• W2017658047 hasConcept C2779631663 @default.
• W2017658047 hasConcept C2780416669 @default.
• W2017658047 hasConcept C2780868878 @default.
• W2017658047 hasConcept C501593827 @default.
• W2017658047 hasConcept C71924100 @default.
• W2017658047 hasConcept C86803240 @default.
• W2017658047 hasConcept C89423630 @default.
• W2017658047 hasConcept C90924648 @default.
• W2017658047 hasConcept C94665300 @default.
• W2017658047 hasConceptScore W2017658047C126322002 @default.
• W2017658047 hasConceptScore W2017658047C159654299 @default.
• W2017658047 hasConceptScore W2017658047C203014093 @default.
• W2017658047 hasConceptScore W2017658047C2776217527 @default.
• W2017658047 hasConceptScore W2017658047C2776938444 @default.
• W2017658047 hasConceptScore W2017658047C2779631663 @default.
• W2017658047 hasConceptScore W2017658047C2780416669 @default.
• W2017658047 hasConceptScore W2017658047C2780868878 @default.
• W2017658047 hasConceptScore W2017658047C501593827 @default.
• W2017658047 hasConceptScore W2017658047C71924100 @default.
• W2017658047 hasConceptScore W2017658047C86803240 @default.
• W2017658047 hasConceptScore W2017658047C89423630 @default.
• W2017658047 hasConceptScore W2017658047C90924648 @default.
• W2017658047 hasConceptScore W2017658047C94665300 @default.
• W2017658047 hasIssue "1" @default.
• W2017658047 hasLocation W20176580471 @default.
• W2017658047 hasLocation W20176580472 @default.
• W2017658047 hasOpenAccess W2017658047 @default.
• W2017658047 hasPrimaryLocation W20176580471 @default.
• W2017658047 hasRelatedWork W1980335198 @default.
• W2017658047 hasRelatedWork W2057847477 @default.
• W2017658047 hasRelatedWork W2074251506 @default.
• W2017658047 hasRelatedWork W2158462590 @default.
• W2017658047 hasRelatedWork W2409363622 @default.
• W2017658047 hasRelatedWork W2804364951 @default.
• W2017658047 hasRelatedWork W42206370 @default.
• W2017658047 hasRelatedWork W4307582922 @default.
• W2017658047 hasRelatedWork W4319161325 @default.
• W2017658047 hasRelatedWork W2502054883 @default.
• W2017658047 hasVolume "87" @default.
• W2017658047 isParatext "false" @default.
• W2017658047 isRetracted "false" @default.

• next